Clinical Trial Update: Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of bexagliflozin as add-on to metformin in type 2 diabetes; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)

Snippet

Sponsor: Theracos | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-07-07